Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic Patients
Clinical trial NCT00882518 · COMPLETED
Trial details
- NCT number
- NCT00882518
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2010-07-01
- Enrollment
- 388
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.